chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My husband said he was feeling very tired about receiving the vaccination. He started to look grey and pale looking, he was very achy. Over the weekend he was light headed, unsteady , and sleeping a lot. His appetite and fluid intake was not the same. On Tuesday, he had a scheduled appointment with his doctor for Chemo, his results showed his white blood cell count was low at 0.59. The doctor suggested  for him to stay home.
Pt called 1 day after receiving vaccines and said she had broke out in hives on her right arm by her tatoo. Pt states a history of hives and they alway occur on her tatoo. Normal redness, swelling and pain noted at injection site (left deltoid). She took 3 doses of Benadryl and hives went away.  She wonders if she should take the 2nd dose of Shingrix. I advised her to continue with Benadryl if hives perssist, monitor and speak with MD about second dose. Because she has a history of hives its difficult to tell if it was a cause. I am unsure if she called an ER or went to the ER.
The patient was intended to receive a 2nd monovalent 5-11-year-old Pfizer COVID-19 vaccine to complete her initial series. Initially, the patient erroneously received a 6-month-4-year-old monovalent Pfizer vaccine at age 5.  She was called back in and received her first 5-11-year-old monovalent Pfizer COVID-19 vaccine.  When the nurse checked her immunization history, she did not check the patient's age when she received the 6-month-4-year-old monovalent Pfizer vaccine. She incorrectly assumed the patient was scheduled for the 6month-4year old bivalent  Pfizer vaccine. (Last of the new primary series)
Blood clots in right thigh. Deep Vein Thrombosis. Pain, swelling, redness.
Central Retinal Vein Occlusion; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: El9261), via an unspecified route of administration administered in left arm on 01Feb2021 (at the age of 71-year-old) as SINGLE DOSE for COVID-19 immunisation. The patient had no other vaccine in four weeks. The patient had no COVID prior vaccination and was not COVID tested post vaccination. Medical history included high blood pressure, premature ventricular contractions (PVC's), and cholesterol. The patient has a known allergy with meclizine. Concomitant medications included acebutolol, aspirin [acetylsalicylic acid] (ASPIRIN), atorvastatin, valsartan, and unspecified vitamin. On 04Feb2021, the patient experienced central retinal vein occlusion. Therapeutic measures were taken as a result of central retinal vein occlusion which included intravitreal avastin injection. The patient had not yet recovered from the event.
Minimal soreness of arm, but day 2 whole body aches and moderate severe headaches intermittent since, now at 1 week post vaccine. Earaches moderate beginning day 6. Joint aches intermittent since vaccine. Symptoms disrupted health enough to miss work as an RN which has never happened, it feels as bad as actually getting sick.  As a nurse myself I did not require a hospital or urgent care visit, treated at home with supportive care.
low fever (100F); headache; muscle ache; This is a spontaneous report from a contactable consumer. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 16Feb2021 09:00 as single dose for covid-19 immunization. Patient was 64-years-old at the time of vaccination. Vaccination facility type was workplace clinic. The patient medical history and concomitant medications were not reported. No Known allergies. On 26Jan2021, the patient received other pfizer vaccine within 4 weeks. No other medications in two weeks. No prior covid vaccination. No covid tested post vaccination. On 17Feb2021 at 01:00, patient experienced Low fever (100F), headache, muscle ache. The events assessed as non-serious. No treatment received. The outcome of the events was unknown.  Information about lot/batch number has been requested.
pt recvd vax 6OCT92 & devel rash & t101; rash began on stomach, back progressive to large hive-like eruptions on neck, back arms, torso w/itch; MD states hives & recommended OTC DPH;
Pt had fever, chills, prickly skin, very fatigued, after vaccine. Immediately with injection pt. felt pain then 7pm whole arm hurt. Pt. reported feeling achy and nauseous.
Before receiving her COVID vaccine today, the patient mentioned that she has previously passed out after receiving shots. Within minutes of receiving her vaccine, she became really clammy and dizzy. My staff pharmacist and I were prepared to help her, since she mentioned this happening before. She never lost consciousness, but ended up needing to lay on the floor with a pillow under her head. We also gave her a cold compress to apply to her face. After resting awhile, we helped her stand up and she was ultimately fine to go home.
Hospitalization: 5/2/2023 - 5/7/2023 (5 days) Presentation to the ED: acute respiratory failure with hypoxia COVID + date: 5/2/23 Treatment: Remdesivir  Discharge to: home.   EL9267 2/15/2021 EW0186 5/24/2021 FJ1620 12/3/2021
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date between 07-MAY-2018 and 10-JUL-2018, the patient was vaccinated with an improperly stored dose of VAQTA, lot # N026997, expiration date 10-NOV-2018; and ROTATEQ, lot # R002060, expiration date 05-JUN-2019 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 47 to 77 degrees (also reported as "max 55 degrees") Fahrenheit for 30 minutes and above 32 up to 35 degrees Fahrenheit for 16 hours (also reported as "brief intervals of being too cold lasting for 30 minutes each, ranging from 34 to 35.6 degrees Fahrenheit"). Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1807USA009780: US-009507513-1808USA006765: US-009507513-1808USA006766: US-009507513-1808USA006767: US-009507513-1808USA006768: US-009507513-1808USA006769: US-009507513-1808USA006771: US-009507513-1808USA006772: US-009507513-1808USA006773: US-009507513-1808USA006774: US-009507513-1808USA006775: US-009507513-1808USA006776: US-009507513-1808USA006777: US-009507513-1808USA006778.
Four days after vaccine booster started having serious pain in right ankle, leg and back. Went to Emergency Room at a local Hospital on 11-25-2021 (Thanksgiving Day) with severe leg/ back pain.  Numerous tests were done in hospital and nothing was found.  Sent home on the 29th and health declined rapidly. Started having extreme leg/ back pain.  Started having severe memory issues and also started hallucinating.  Legs became very weak and he couldn?t stand on his own. Became very weak.  Took him for an MRI on 01/05/2022 and it was negative: no stroke, mass effect or bleed.  Lost all control of legs and memory declined severely and frequent hallucinations. Died on 01-22-2922.
4 joints of my fingers that are inflamed; not being able to move; This serious case was reported by a consumer and described the occurrence of joint inflammation in a 56-year-old male patient who received Herpes zoster (Shingles vaccine) (batch number 2R375, expiry date 05-MAY-2024) for prophylaxis.   On 06-JUN-2023, the patient received Shingles vaccine. On 06-JUN-2023, less than a day after receiving Shingles vaccine, the patient experienced joint inflammation (Verbatim: 4 joints of my fingers that are inflamed) (serious criteria hospitalization and other: as per reporter) and mobility decreased (Verbatim: not being able to move) (serious criteria hospitalization and other: as per reporter). The patient was treated with famotidine. The outcome of the joint inflammation and mobility decreased were not resolved.   It was unknown if the reporter considered the joint inflammation and mobility decreased to be related to Shingles vaccine.     It was unknown if the company considered the joint inflammation and mobility decreased to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 28-JUL-2023 The reporter was a patient. The reporter reported that after taking Shingles vaccine he had serius problems, of not being able to move, where a had to be taken to the hospital by ambulance, he had 4 joints of his fingers that were inflamed, patient asked for help. The patient was in hospital for hours after taking the vaccine. The other product used IC famotidine for unknown indication. The patient need helped to find a medicine, he had been living this nightmare for 2 months after vaccine. The reporter reported that the physician said that they would never sow a case like this. The reporter requested to consent the follow up.
heart rate racing up to 125-149 beats per minute; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Feb2021 18:30 (Lot number: EN5318) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism" (unspecified if ongoing); "Graves Disease" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; VITAMIN D [COLECALCIFEROL]; PROBIOTIC [BIFIDOBACTERIUM INFANTIS;LACTOBACILLUS ACIDOPHILUS]. Past drug history included: Toradol, reaction(s): "Drug allergy: Toradol". The following information was reported: PALPITATIONS (non-serious) with onset 07Feb2021 21:00, outcome "recovered" (Feb2021), described as "heart rate racing up to 125-149 beats per minute". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of palpitations.  Additional information: after 1st dose, 2nd night patient heart rate racing up to 125-149 beats per minute, next morning it was fine, 2nd dose 2nd night heart started to increase again this time she learned tips to lower heart rate cold pack on face did immediately and was able to keep heart rate to 103 beats per minute she was fine at next morning. Restlessness/lack of sleep-nightmares and other general common well documented symptoms. patient had not got any prior vaccinations, no tested for Covid post vaccinations.   No follow-up attempts are possible. No further information is expected.
Approximately 3 - 4 hrs after vaccine administration, patient was in stroller noted to have pallor, vomiting with loss of consciousness. No jerking or tremors noted. Lasted 1 - 2 min. EMT's called and taken to ER - noted temp 103. In ER, noted normal UA and negative urine culture. Patient recovered, followed up the next day and was well.
felt as if she had covid again/ felt the same symptomatology (like when she had covid); 5 centimeters protuberance in the injection site; Back pain; she had no appetite; she couldn't swallow water but it wasn't like her throat was closing; had body weakness; felt like the swelling was tightening her; had headache like if her head is going to explode; Nauseas; Muscle pain/Body ache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (felt as if she had covid again/ felt the same symptomatology (like when she had covid)), VACCINATION SITE MASS (5 centimeters protuberance in the injection site), BACK PAIN (Back pain), DECREASED APPETITE (she had no appetite) and DYSPHAGIA (she couldn't swallow water but it wasn't like her throat was closing) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025Z1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had COVID 2 times in the past and was hospitalized.). Concomitant products included GABAPENTIN for an unknown indication.    On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jul-2021, the patient experienced SUSPECTED COVID-19 (felt as if she had covid again/ felt the same symptomatology (like when she had covid)), VACCINATION SITE MASS (5 centimeters protuberance in the injection site), BACK PAIN (Back pain), DECREASED APPETITE (she had no appetite), DYSPHAGIA (she couldn't swallow water but it wasn't like her throat was closing), ASTHENIA (had body weakness), VACCINATION SITE SWELLING (felt like the swelling was tightening her), HEADACHE (had headache like if her head is going to explode), NAUSEA (Nauseas), MYALGIA (Muscle pain/Body ache) and PYREXIA (Fever). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at a dose of 500 mg and CAFFEINE (CAFEINE) for Myalgia and Headache, at a dose of 32.5 mg. At the time of the report, SUSPECTED COVID-19 (felt as if she had covid again/ felt the same symptomatology (like when she had covid)), BACK PAIN (Back pain), DECREASED APPETITE (she had no appetite), DYSPHAGIA (she couldn't swallow water but it wasn't like her throat was closing), ASTHENIA (had body weakness), HEADACHE (had headache like if her head is going to explode), NAUSEA (Nauseas), MYALGIA (Muscle pain/Body ache) and PYREXIA (Fever) was resolving and VACCINATION SITE MASS (5 centimeters protuberance in the injection site) and VACCINATION SITE SWELLING (felt like the swelling was tightening her) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug included anti-inflammatory medications and thyroid medications.
feeling pain; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (feeling pain) and FATIGUE (Tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (feeling pain) and FATIGUE (Tired). At the time of the report, PAIN (feeling pain) and FATIGUE (Tired) had resolved.      No Concomitant medications were reported. It was reported that patient received all three doses. Reporter said it was not a side effect and it was normal. No treatment medications were reported.
Immediately after the vaccine I felt a forehead headache that went to the back of my head. I thought it would go away as week and a half and went to the doctor and found out I had a sinus infection. I've not had a sinus infection in a long time. Also, the doctor said that others had reported having headaches after the vaccine.  Also two weeks to the day after the vaccine my eyes went funny and I couldn't ready or see properly and it was noted that I had a TIA and was diagnosed of having A-fib..
Tiredness; This is a spontaneous report from a non-contactable Pharmacist reporting for a patient.  A female patient (unknown if pregnant) of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported) via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation . The patient medical history and concomitant medications were not reported. It was unknown if patient had covid prior vaccination and if was covid tested post vaccination.On an unknown date the patient experienced tiredness post vaccination. Unknown if treatment were given. The  outcome of the event was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.
Swelling, redness and itching right deltoid at site of injection. Use OTC BENADRYL.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. No information on patients' concurrent conditions, medical history or concomitant medications was provided. On an unknown dates, unspecified number of patients received improperly stored doses of VARIVAX injection, lot # K009757, expiration date 09-JUL-2016 (dose and route of administration were not reported). No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
This case was reported by a consumer and described the occurrence of nerve disturbance in a male subject aged between 70 and 79 years old who was vaccinated with influenza virus vaccine (manufacturer unspecified). The reporter is the wife of the subject. A physician or other health care professional has not verified this report. The subject's medical history included reaction to preservatives. This subject had no adverse events following receipt of prior immunizations with influenza virus vaccines and had no known adverse events following receipt of previous vaccinations. Concurrent medications included ACTONEL and AXID. On 14 October 2008 at 12:00 p.m., the subject received the "one and only" dose of Influenza virus vaccine (unknown). On 15 October 2008, 1 day after vaccination with Influenza virus vaccine, the subject experienced nerve disturbance described as "nerve endings felt weird," diarrhea and total exhaustion. The subject consulted a healthcare professional regarding the event. At the time of reporting the events were unresolved. The reporter is the subject's wife and stated that exhaustion is not flu-like. She could not further describe what she meant by nerve endings feeling weird. The subject received his flu vaccine at a clinic inside a pharmacy. She said that she does not know for sure if he received a GSK flu vaccine. The consumer reported that one other subject experienced adverse events following receipt of FLULAVAL. Please see case A0753986A.
Information has been received from a mother concerning her child who was vaccinated with a dose of hepatitis B virus vaccine rHBsAg (yeast). Concomitant vaccine included a dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid. It was reported that the child was having medical issues. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Developed Ramsey Hunt Syndrome  Severe left facial nerve paralysis, decrease hearing left side and  severe vertigo with nausea vomiting requiring hospitalization
red swollen hot area on arm started approximately 2 days after vaccine.  It is spreading up and down the arm and has spread around all sides.  From shoulder to wrist.
Pt vaccinated with Influenza developed rash starting under lft arm (side vaccine was given on); rash spread over both arms, back, & abd. Skin appears scalded w/blistery areas; reaction systemic. Referred to ER.
swollen at injection site; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038821A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swollen at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site). On 27-Mar-2021, VACCINATION SITE SWELLING (swollen at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No concomitant medications were provided. No treatment information was provided.   This case was linked to MOD21-088140, US-MODERNATX, INC.-MOD-2021-114482 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Updated events of dose 1.; Sender's Comments:  MOD21-088140: US-MODERNATX, INC.-MOD-2021-114482:Dose 2
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Medical history and drug reactions/allergies were not reported. On 16-OCT-2014, the patient was vaccinated with GARDASIL lot # J009788 expiry date 17-MAR-2016, intramuscular (dose not reported) which underwent an unsupported temperature excursion. Concomitant medication was not reported. No adverse effects reported. Additional information has been requested.
1st night: fever, swelling, pain, redness, stomach upset, sleeplessness. 2nd and 3rd  day: heat, redness, extreme swelling, pain/soreness, swollen lymph nodes.
PFizer vaccine was administered after being discovered that the vaccines were in the freezer for 11 days after the two-week standard time.
Pt presented on 10/13/07 with a vesicular dermatomal rash on R leg which was clinically significant with Zoster.  Pt never had chicken pox, but did have the Varicella vaccine on 11/8/06
Sore left arm, outer muscle, near shoulder and deep pain in socket of shoulder as well as knotted trapezius muscles in left shoulder and back, starting 09/30/2005.  On 10/20 the doctor prescribed that sore muscles be treated with daily muscle relaxers patient had from a previous doctor, and with hot compresses for 10 days, then return.
At onset at 9:00PM congestion and scratchy throat and coughing. Body aches during night. Increased body aches in A.M and watery, itchy eyes with discharge in A.M. Self medicated with Allegra at 9:00PM and 800mg. Advil p.o.in A.M. of 9/29/2011. Given Natural tear drops at 3:00PM 9/29/2011 for comfort.
Subjective tingling to tongue and questionable subjective swelling but no visible swelling no hives no trouble breathing.  Spontaneously began to resolve in a couple of minutes.  Advised to see allergist before second dose.
PATIENT REPORTS ARM STILL HURTS 28 DAYS AFTER VACCINATION. PAIN RADIATES FROM NECK TO FOREARM. ARM IS OFTEN COLD.
4:30 sore left arm, 10:30 pm Chills and fever,  Chilles and fever over about 4am Sunday 03/21 .   8 am Sunday  Headache    Achey body until about 3:00pm   Monday 3/22 headache   Swollen symph nodes 3/22   9am to present  Very tired on Sunday all day
Information has been received from a physician concerning a 63 year old female patient who on 11-JUN-2009 was vaccinated with a single 0.5ml dose of ZOSTAVAX (Merck) (lot number, route and site not reported). Subsequently, the patient experienced significant redness and swelling at the injection site. The patient did not seek medical attention. At the time of the report, the patient's outcome was unknown. Follow-up information received from a medical assistant indicated that on 11-JUN-2009, at 9:15a.m., the patient received the first dose of ZOSTAVAX (Merck) (lot#663177/1413X) subcutaneously into left arm. There were no pre-existing allergies, birth defects, medical conditions and illness at time of vaccination. On 11-JUN-2009, at 10:00a.m., the patient developed erythema at area of injection site and body aches immediately, the patient's temperature was 100 deg F. At the time of the report, the patient's outcome was unknown. Erythema at area of injection site, body aches and fever were considered to be an other important medical events by the medical assistant. Additional information has been requested.